Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3b Study to Investigate the Effect of 0.003% AR-15512 on the Ocular Surface Characteristics of Subjects With Dry Eye Disease

NCT06544694 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT06544694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06544694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3b Study to Investigate the Effect of 0.003% AR-15512 on the Ocular Surface Characteristics of Subjects With Dry Eye Disease
Lead sponsor
Alcon Research
Phase
Phase 3
Overall status
Completed
Start date
October 8, 2024
Completion date
March 21, 2025
Enrollment
80 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease